The development of this Guidelines video has been supported by an educational grant from Napp Pharmaceuticals Limited. Napp Pharmaceuticals Limited had no influence over the selection of the speaker or the content of the video, and checked the final files for technical accuracy only.
Latest formulary decision guides
Patient Passport—Hepatic encephalopathy
Developed by Norgine Pharmaceuticals Limited as a service to patients
Date of preparation March 2018
The Patient Passport is a practical document to help patients keep information to hand relating to their condition—hepatic encephalopathy. It includes space to track their medications, clinical information, and instructions given by their healthcare team.